CSR Conclave: 'Empowering Tribals through CSR' (See 'Corp Brief') CSIR & MEA jointly host Ambassadors from Global South (See 'Corp Brief') Nadda reaffirms India's Commitment to Eliminate TB Ahead of Global Targets (See 'Corp Brief') Ministry of Ayush and DBT announce collaborative Clinical Study on Ayurveda (See 'Corp Brief') IBC - Issues of fraud or existence of debt must be decided by insolvency tribunal, not civil court: HC (See 'Legal Desk') RBI strengthens Framework on Unauthorised Electronic Banking Transactions (See 'Corp Brief') Govt expands DEH Initiative to Boost District-Level Export Competitiveness (See 'Corp Brief') DPIIT signs MoU with leading AC company to strengthen manufacturing ecosystem (See 'Corp Brief') Two-Day Eastern Region Review Meeting of CGCA concludes (See 'Corp Brief') IPR - Minor variations in product that do not alter essential mode of operation of patented invention are considered mere engineering variations: HC (See 'Legal Desk') Paatil calls for 'Jan Bhagidari' to strengthen Water Conservation Efforts (See 'Corp Brief') IICA successfully concludes 4th Batch of Directors' Certification in Corporate Governance (See 'Corp Brief') Ministry of MSME assisting entrepreneurs in setting up of new micro enterprises (See 'Corp Brief') COFEPOSA - Dispute over rent or mesne profits for immovable property leased for commercial purposes is 'commercial dispute': HC (See 'Legal Desk') Amendments to Banking Regulation Act and MSCS Act, 2002 enhance oversight & accountability (See 'Corp Brief') MY Bharat mobilises Youth across 763 Districts for Shaheed Diwas Padyatra (See 'Corp Brief') PMLA - Even property acquired prior to commission of crime can be provisionally attached finding it falling in definition of 'proceeds of crime': SAFEMA (See 'Legal Desk') Ministry of Mines to launch 7th Tranche of Auction of Critical and Strategic Minerals (See 'Corp Brief') Jal Mahotsav 2026 gives momentum to 'Jal Sanchay se Jan Bhagidari' (See 'Corp Brief') Ministry of Mines to organise National DMF Summit 2026 (See 'Corp Brief') PMLA - High Court of Delhi lacked territorial jurisdiction to hear appeal filed against Appellant based in Kolkata; GST registration at Delhi, occasional hearings before Delhi Bench of NCLT do not establish that appellant ordinarily operates in Delhi: HC (See 'Legal Desk') Union Minister chairs 90th Meeting of Standing Committee of National Board for Wildlife (See 'Corp Brief') India achieves 1 billion Tonne Coal Production Milestone Again (See 'Corp Brief') Capital Market - SEBI's regulations are framed to protect rights of stakeholders in securities market, and violation of its regulations being matter of public law, can't be condoned by private resolution of shareholders: SC (See 'Legal Desk') PDUNASS conducts DoPT-Sponsored Training Programme (See 'Corp Brief') Govt introduces Credit Guarantee Scheme for Microfinance Institutions-2.0 (See 'Corp Brief') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

Print

Ministry of Ayush and DBT announce collaborative Clinical Study on Ayurveda

Published: Mar 25, 2026

By TIOLCorplaws News Service

NEW DELHI, MAR 25, 2026: ON the occasion of World Tuberculosis (TB) Day, the Union Ministry of Ayush in partnership with the Department of Biotechnology (DBT), Ministry of Science & Technology marked a significant milestone in integrative healthcare with the formal announcement of a collaborative clinical study titled “Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis”.

The joint announcement was made by Dr. Jitendra Singh, Hon'ble Minister of State (Independent Charge), Ministry of Science and Technology and Ministry of Earth Sciences, Minister of State, PMO, Ministry of Personnel, Public Grievances and Pensions, Department of Atomic Energy and Department of Space and Prataprao Jadhav, Hon'ble Minister of State (Independent Charge) of the Ministry of Ayush and Minister of State in the Ministry of Health & Family Welfare in the presence of senior officials and scientists of the Ministries. The high-level event, held at Vigyan Bhawan, also brought together leading policymakers, scientists, scholars, researchers, clinicians, and other key stakeholders to underscore India's commitment to evidence-based integration of traditional and modern medicine in the fight against tuberculosis.

In his address, Dr. Jitendra Singh, Hon'ble Minister of State (Independent Charge), Ministry of Science and Technology and Ministry of Earth Sciences, Minister of State, PMO, Ministry of Personnel, Public Grievances and Pensions, Department of Atomic Energy and Department of Space, stated: “India is moving in the right direction in its fight against tuberculosis, with a significant decline in incidence driven by dedicated and innovative efforts under the leadership of the Hon'ble Prime Minister Narendra Modi,” He added, “The launch of this collaborative clinical study reflects our commitment to science-led, evidence-based innovation, integrating modern biomedical research with validated traditional knowledge systems. Through initiatives led by the Department of Biotechnology, we are strengthening research, fostering global partnerships, and advancing patient-centric solutions to address challenges such as drug resistance, undernutrition, and long-term health impacts of TB.”

In his address, Prataprao Jadhav, Hon'ble Minister of State (Independent Charge) of the Ministry of Ayush and Minister of State in the Ministry of Health & Family Welfare, emphasised: “The treatment of tuberculosis is not only about eliminating the infection, but about making the patient completely healthy. With this approach, we are moving towards a new perspective where Ayurveda and other Ayush systems are not only supportive in treatment but also play an important role in improving recovery, nutrition, and the quality of life of patients.”

The programme commenced with opening remarks by Dr. Rajesh S. Gokhale, Secretary, DBT; Director General, BRIC and Chairman, BIRAC, who highlighted: “Tuberculosis research in India has seen remarkable advances through innovation in diagnostics, vaccines, and large-scale cohort studies. This collaborative programme with the Ministry of Ayush marks a significant step towards integrative, evidence-based healthcare. By combining modern science with Ayurveda, we aim to improve patient outcomes, enhance quality of life, and accelerate India's mission to eliminate TB.”

This was followed by remarks from Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush, who remarked: “Tuberculosis management requires not only effective treatment but also a focus on recovery and quality of life. This Ayush–DBT collaborative initiative reflects our commitment to evidence-based integrative healthcare. By combining Ayurveda with science, we aim to address TB-associated cachexia, strengthen patient outcomes, and contribute meaningfully to India's goal of TB elimination.”

An overview of the collaborative clinical study was presented by Prof. Vaidya Rabinarayan Acharya, Director General, Central Council for Research in Ayurvedic Sciences (CCRAS), along with Dr. Debasisa Mohanty, Director, BRIC-National Institute of Immunology (NII). The presentation detailed the scientific design, objectives, and expected outcomes of the study, which aims to evaluate the efficacy, safety, and tolerability of an Ayurveda regimen as an adjunct to standard anti-tuberculosis treatment (ATT), along with macronutrient supplementation.

The collaborative clinical study is a joint initiative of the Ministry of Ayush and the Department of Biotechnology, rooted in the MoU signed in May 2022 to advance integrative and evidence-based healthcare. Led by the Central Council for Research in Ayurvedic Sciences (CCRAS) in partnership with DBT, the multi-centre study will assess the efficacy, safety, and tolerability of an Ayurveda regimen as an adjunct to standard Anti-Tuberculosis Treatment (ATT), along with nutritional support. To be conducted across premier institutions including AIIMS, JIPMER, and NEIGRIHMS, the 24-month study aims to generate robust scientific evidence on improving nutritional outcomes, accelerating recovery, and enhancing quality of life among TB patients, further strengthening India's commitment to innovative, patient-centric approaches for TB elimination.

A key highlight of the event was the exchange of a Memorandum of Understanding (MoU) between BRIC-Translational Health Science and Technology Institute (THSTI) and CCRAS, formalising institutional collaboration. The MoU was exchanged between Prof. G. Karthikeyan, Executive Director, BRIC-THSTI, and Prof. Vaidya Rabinarayan Acharya, DG, CCRAS.

The event concluded with a strong reaffirmation of the Government of India's commitment to advancing integrative, evidence-based healthcare solutions to address complex public health challenges. The Ayush–DBT collaborative initiative is expected to pave the way for new scientific insights into adjunct TB care, while reinforcing India's leadership in combining traditional knowledge with modern biomedical research for improved patient outcomes and accelerated progress towards TB elimination.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.